The PI3k/Akt Pathway Is Associated With Angiogenesis, Oxidative Stress and Survival of Mesenchymal Stem Cells in Pathophysiologic Condition in Ischemia
-
Published:2019-11-30
Issue:
Volume:
Page:S131-S138
-
ISSN:1802-9973
-
Container-title:Physiological Research
-
language:en
-
Short-container-title:Physiol Res
Author:
SAMAKOVA A., GAZOVA A.1, SABOVA N., VALASKOVA S., JURIKOVA M., KYSELOVIC J.
Affiliation:
1. Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovak Republic
Abstract
Ischemic diseases are characterized by reduced blood supply to a tissue or an organ due to obstruction of blood vessels. The most serious and most common ischemic diseases include ischemic heart disease, ischemic stroke, and critical limb ischemia. Revascularization is the first choice of therapy, but the cell therapy is being introduced as a possible way of treatment for no-option patients. One of the possibilities of cell therapy is the use of mesenchymal stem cells (MSCs). MSCs are easily isolated from bone marrow and can be defined as non-hematopoietic multipotent adult stem cells population with a defined capacity for self-renewal and differentiation into cell types of all three germ layers depending on their origin. Since 1974, when Friedenstein and coworkers (Friedenstein et al. 1974) first time isolated and characterized MSCs, MSC-based therapy has been shown to be safe and effective. Nevertheless, many scientists and clinical researchers want to improve the success of MSCs in regenerative therapy. The secret of successful cell therapy may lie, along with the homing, in secretion of biologically active molecules including cytokines, growth factors, and chemokines known as MSCs secretome. One of the intracellular signalling mechanism includes the activity of phosphatidylinositol-3-kinase (phosphoinositide 3-kinase) (PI3K) - protein kinase B (serine-threonine protein kinase Akt) (Akt) pathway. This PI3K/Akt pathway plays key roles in many cell types in regulating cell proliferation, differentiation, apoptosis, and migration. Pre-conditioning of MSCs could improve efficacy of signalling mechanism.
Publisher
Institute of Physiology of the Czech Academy of Sciences
Subject
General Medicine,Physiology
Reference28 articles.
1. ABOYANS V, RICCO JB, BARTELINK M-LEL, BJÖRCK M, BRODMANN M, COHNERT T, COLLET JP, CZERNY M, DE CARLO M, DEBUS S, ESPINOLA-KLEIN C, KAHAN T, KOWNATOR S, MAZZOLAI L, NAYLOR AR, ROFFI M, RÖTHER J, SPRYNGER M, TENDERA M, TEPE G, VENERMO M, VLACHOPOULOS C, DESORMAIS I, DOCUMENT REVIEWERS: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal, 2017. 2. BECKWITT CH, BRUFSKY A, OLTVAI ZN, WELLS A: Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res 20: 144-155, 2018. 3. CARSON RA, RUDINE AC, TALLY SJ, FRANKS AL, FRAHM KA, WALDMAN JK, SILSWAL N, BURALE S, PHAN JV, CHANDRAN UR, MONAGHAN AP, DEFRANCO DB: Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms. PLOS ONE 13: e0196387, 2018. 4. FERREIRA JR, TEIXEIRA GQ, SANTOS SG, BARBOSA MA, ALMEIDA-PORADA D, GONÇALVES RM: Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Frontiers in Immunology 9: 2837, 2018. 5. FRIEDENSTEIN AJ, DERIGLAZOVA UF, KULAGINA NN, PANASUK AF, RUDAKOWA SF, LURIÁ EA, RUADKOW IA: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2: 83-92, 1974.
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|